Topical Gel/Microsphere Eyedrop for Combined Delivery of Brimonidine and Timolol: A Comparative Study With Traditional Eye Drops in Rabbits
Translational Vision Science & Technology · 2025
DOI: 10.1167/tvst.14.7.15 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Xin Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Timolol, Brimonidine Tartrate, Antihypertensive Agents, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Purpose
Topical eye drops combining multiple antiglaucoma agents are often required when monotherapy fails to reduce intraocular pressure (IOP). However, their effectiveness is compromised by low bioavailability and poor patient compliance. To address these issues, we developed a novel gel/microsphere eye drop (GME) containing brimonidine and timolol, aimed at enhancing ocular bioavailability, reducing dosing frequency, and improving patient compliance.
Methods
The GME system comprises separate formulations of brimonidine-loaded and timolol-loaded polymer microspheres within a thermoresponsive hydrogel, enabling simple off-the-shelf preparation. We examined the in vitro drug release, compared the biodistribution with traditional eye drops, and assessed pharmacodynamic effects in New Zealand white rabbits and Dutch Belted rabbits.
Results
Brimonidine and timolol reached high concentrations in the aqueous and vitreous humor at 1 hour following eye drop administration, declining to nearly undetectable levels by 24 hours. The GME system at a similar dose extended the drug release to 27 days with initially lower drug levels but decreasing more slowly. The GME system also resulted in significantly lower plasma drug concentrations than eye drops, suggesting a reduced risk of systemic side effects. Neither the GME nor eye drops significantly reduced IOP in normotensive rabbits.
Conclusions
The GME system presents a promising alternative to traditional eye drops for controlled drug release in ocular applications, enabling sustained drug delivery while minimizing systemic exposure and thereby potentially enhancing the safety and efficacy of ocular therapies. Translational Relevance: The GME system bridges basic research and clinical application by providing a controlled-release platform that sustains drug delivery, reduces systemic side effects, and enhances patient adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
- Small Molecule Biomarker Core, Department of Pharmacy & Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Chemical Engineering, University of Pittsburgh, Pittsburgh, PA, USA.
Förderung
- NEI NIH HHS
- NIH HHS
- NCRR NIH HHS
Zitieren
APA
Fan, X., Harding, P. A., Ziaei, P., Chaudhry, A. B., West, R. E., Nolin, T. D., & DiLeo, M. V. (2025). Topical Gel/Microsphere Eyedrop for Combined Delivery of Brimonidine and Timolol: A Comparative Study With Traditional Eye Drops in Rabbits. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.7.15
Vancouver
Fan X, Harding PA, Ziaei P, Chaudhry AB, West RE, Nolin TD, et al. Topical Gel/Microsphere Eyedrop for Combined Delivery of Brimonidine and Timolol: A Comparative Study With Traditional Eye Drops in Rabbits. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.7.15
BibTeX
@article{Fan2025,
author = {Fan, Xin and Harding, Phillip A and Ziaei, Parissa and Chaudhry, Ahmad B and West, Raymond E and Nolin, Thomas D and DiLeo, Morgan V},
title = {Topical Gel/Microsphere Eyedrop for Combined Delivery of Brimonidine and Timolol: A Comparative Study With Traditional Eye Drops in Rabbits},
journal = {Translational Vision Science & Technology},
year = {2025},
doi = {10.1167/tvst.14.7.15}
}
EUVIMED